Prediabetes Market is Projected to Boost at a Moderate Growth Rate by 2034, Predicts DelveInsight | Key Companies – Novo Nordisk, Aphaia Pharma, HighTide Biopharma Pty Ltd, Eli Lilly and Company, Corcept Therapeutics

There is a huge unmet need in the prediabetes market for approved therapies since their effective treatment and management can lead to the prevention of diabetes. There are no US FDA-approved drugs available for the treatment of prediabetes. Companies like Novo Nordisk (semaglutide) and…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.